VJHemOnc is committed to improving our service to you

ASCO 2019 | MRD: decision making in CLL

VJHemOnc is committed to improving our service to you

Susan O’Brien

MRD offers a huge advantage in the development of prognostics in chronic lymphocytic leukemia (CLL), but how does the technique impact decision making in the clinical environment? Susan O’Brien, MD, of the University of California Irvine, Irvine, CA, discusses this at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter